122 related articles for article (PubMed ID: 8826549)
1. Pain assessment of subcutaneous injections.
Jørgensen JT; Rømsing J; Rasmussen M; Møller-Sonnergaard J; Vang L; Musaeus L
Ann Pharmacother; 1996; 30(7-8):729-32. PubMed ID: 8826549
[TBL] [Abstract][Full Text] [Related]
2. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
[TBL] [Abstract][Full Text] [Related]
3. A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.
Portron A; Jordan P; Draper K; Muenzer C; Dickerson D; van Iersel T; Hofmann C
Clin Ther; 2020 Jan; 42(1):108-120.e1. PubMed ID: 31883703
[TBL] [Abstract][Full Text] [Related]
4. A trial comparing local pain after subcutaneous injection of epoetin-beta versus darbepoetin-alpha in healthy volunteers.
Berthoux F; Ryckelynck JP; Rouanet S; Gelu-Mantoulet S; Montestruc F; Mouchel P; Choukroun G;
Clin Nephrol; 2008 Jul; 70(1):33-40. PubMed ID: 18793546
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
Dias C; Abosaleem B; Crispino C; Gao B; Shaywitz A
AAPS PharmSciTech; 2015 Oct; 16(5):1101-7. PubMed ID: 25693652
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa.
Pannier A; Jordan P; Dougherty FC; Bour F; Reigner B
Curr Med Res Opin; 2007 Dec; 23(12):3025-32. PubMed ID: 17961301
[TBL] [Abstract][Full Text] [Related]
7. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
8. Pain perception after subcutaneous injections of media containing different buffers.
Laursen T; Hansen B; Fisker S
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):218-21. PubMed ID: 16445598
[TBL] [Abstract][Full Text] [Related]
9. Impact of Injection Speed, Volume, and Site on Pain Sensation.
Zijlstra E; Jahnke J; Fischer A; Kapitza C; Forst T
J Diabetes Sci Technol; 2018 Jan; 12(1):163-168. PubMed ID: 28990437
[TBL] [Abstract][Full Text] [Related]
10. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
McKay M; Compion G; Lytzen L
Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
[TBL] [Abstract][Full Text] [Related]
11. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients.
Schmitt CP; Nau B; Brummer C; Rosenkranz J; Schaefer F
Nephrol Dial Transplant; 2006 Dec; 21(12):3520-4. PubMed ID: 16935904
[TBL] [Abstract][Full Text] [Related]
12. The influence of injection speed on pain during injection of local anaesthetic.
Tangen LF; Lundbom JS; Skarsvåg TI; Wågø KJ; Ballo S; Hjelseng T; Finsen V
J Plast Surg Hand Surg; 2016; 50(1):7-9. PubMed ID: 26414074
[TBL] [Abstract][Full Text] [Related]
13. An Innovative Needle-free Injection System: Comparison to 1 ml Standard Subcutaneous Injection.
Kojic N; Goyal P; Lou CH; Corwin MJ
AAPS PharmSciTech; 2017 Nov; 18(8):2965-2970. PubMed ID: 28462463
[TBL] [Abstract][Full Text] [Related]
14. Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study.
Granolleras C; Leskopf W; Shaldon S; Fourcade J
Clin Nephrol; 1991 Dec; 36(6):294-8. PubMed ID: 1769141
[TBL] [Abstract][Full Text] [Related]
15. Discomfort assessment in peripheral angiography: randomized clinical trial of Iodixanol 270 versus Ioversol 320 in diabetics with critical limb ischemia.
Palena LM; Sacco ZD; Brigato C; Sultato E; Barra D; Candeo A; Manzi M
Catheter Cardiovasc Interv; 2014 Nov; 84(6):1019-25. PubMed ID: 24478190
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa.
Frenken LA; van Lier HJ; Koene RA
Nephrol Dial Transplant; 1994; 9(9):1295-8. PubMed ID: 7816293
[TBL] [Abstract][Full Text] [Related]
17. Low discomfort and pain associated with intensified insulin therapy in children and adolescents.
Karges B; Muche R; Moritz M; Riegger I; Debatin KM; Heinze E; Wabitsch M; Karges W
Diabetes Res Clin Pract; 2008 Apr; 80(1):96-101. PubMed ID: 18160119
[TBL] [Abstract][Full Text] [Related]
18. Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin Type A Injections: A Randomized Clinical Trial.
Alam M; Geisler A; Sadhwani D; Goyal A; Poon E; Nodzenski M; Schaeffer MR; Tung R; Minkis K
JAMA Dermatol; 2015 Nov; 151(11):1194-9. PubMed ID: 26352252
[TBL] [Abstract][Full Text] [Related]
19. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U
JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710
[TBL] [Abstract][Full Text] [Related]
20. Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta.
Veys N; Dhondt A; Lameire N
Clin Nephrol; 1998 Jan; 49(1):41-4. PubMed ID: 9491285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
